Celsee Revenue and Competitors

Claim your profile

Detroit, MI USA

Location

$12.8M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Celsee's estimated annual revenue is currently $3.4M per year.(i)
  • Celsee's estimated revenue per employee is $155,000
  • Celsee's total funding is $12.8M.

Employee Data

  • Celsee has 22 Employees.(i)
  • 0
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$6.7M0N/A$31.2MN/A
#2
$3.7M24N/AN/AN/A
#3
$7.6M49-6%$66.7MN/A
#4
$1.1M740%N/AN/A
#5
$3.4M22N/A$12.8MN/A
#6
$94.2M608-4%N/AN/A
#7
$8.4M54-2%N/AN/A
#8
$503M18414%N/AN/A
#9
$5M32-3%N/AN/A
#10
$2.3M15N/AN/AN/A

Celsee, Inc. develops, manufactures, and markets integrated comprehensive single-cell analysis solutions that provide an unprecedented combinational ability to accurately identify, analyze and viably retrieve single cells directly from blood and tissue. Celsee's platforms provide a practical approach to accurately analyze previously undetectable or rare cells to a scale of millions of single cells from an individual sample. The patented approach incorporates the fundamental properties of gravity for the gentle capture and isolation of individual cells from heterogeneous blood and tissue suspensions. Celsee's comprehensive single-cell analysis platforms offer a practical solution for understanding and monitoring cell-based diseases. 734-233-3089

keywords:N/A

$12.8M

Total Funding

22

Number of Employees

$3.4M

Revenue (est)

N/A

Employee Growth %

N/A

Valuation

N/A

Accelerator

Celsee News

2018-11-09 - Celsee Charts Expansion Plans as Single-Cell Analysis Demand Grows

Share Share on Facebook Share on Twitter LinkedIn Email Reprints The humble cell has been getting a lot of attention in the medical world lately, and Ann Arbor, MI-based biotech startup Celsee wants to make it easier to study them. As precision medicine and genomic analysis become more sophist ...

08/20/2019 - Single Cell Genomics Market Global Analysis, Trends, Emerging Technology Till 2023 | 10X Genomics, Accelerate Diagnostics, Affymetrix, Agilent Technologies, Celsee Diagnostics

The Latest Study on Single Cell Genomics market during forecast period 2018-2023. A detailed study accumulated to offer Latest insights about ...

10/25/2018 - Celsee Launches Genesis System to Overcome Prior Limits of ...

ANN ARBOR, Mich.--(BUSINESS WIRE)--Celsee, Inc., today launched its first product, the Genesis system, designed to overcome the ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$2.2M22N/AN/A
#2
$3.2M22N/AN/A
#3
$3.9M22N/AN/A
#4
$4.5M26N/AN/A
#5
$4.1M26-7%N/A